10 Things Worth Pay...
Health Care: Drugs
ACADIA Pharmaceuticals Inc. (ACAD: NASDAQ)
$1.33 0.02 | 1.53%
06/04/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 6.89M | 6.85M | 18.12M | 21.17M |
| Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 31.95M | 37.85M | 48.47M | 62.38M |
| Property, Plant & Equipment, Gross | 6.29M | 8.05M | 8.50M | 8.45M |
| Accumulated Depreciation & Depletion | 6.14M | 7.62M | 7.43M | 6.34M |
| Property, Plant & Equipment, Net | 151.00K | 426.00K | 1.06M | 2.10M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 14.00K | 119.00K | 145.00K | 192.00K |
| Total Non-Current Assets | 165.00K | 545.00K | 1.21M | 2.30M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 32.11M | 38.39M | 49.68M | 64.68M |
| Accounts Payable | 1.96M | 1.97M | 2.95M | 2.28M |
| Short Term Debt | 32.00K | 78.00K | 365.00K | 795.00K |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 6.16M | 5.96M | 14.71M | 11.05M |
| Long Term Debt | 0.00 | 32.00K | 98.00K | 430.00K |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 2.59M | 2.72M | 22.76M | 204.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 2.59M | 2.75M | 22.86M | 634.00K |
| Total Liabilities | 8.75M | 8.71M | 37.57M | 11.68M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 23.36M | 29.69M | 12.11M | 52.99M |
| Common Par | 5.00K | 4.00K | 4.00K | 4.00K |
| Additional Paid In Capital | 370.22M | 353.28M | 350.87M | 346.82M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -346.87M | -324.11M | -339.24M | -294.10M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 9.00K | 512.00K | 483.00K | 273.00K |
| Total Capitalization | 23.36M | 29.72M | 12.21M | 53.42M |
| Total Equity | 23.36M | 29.69M | 12.11M | 52.99M |
| Total Liabilities & Stock Equity | 32.11M | 38.39M | 49.68M | 64.68M |
| Total Common Shares Outstanding | 52.90M | 39.35M | 38.33M | 37.18M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 52.18M | 38.59M | 37.48M | 37.11M |
| Diluted Weighted Shares Outstanding | 52.18M | 38.72M | 37.48M | 37.11M |
| Number of Employees | 24 | 27 | 27 | 63 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ACAD
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserBerliner
- Contributor5 Stocks Under-$10 Setting ...
- Contributor10 Pharma Stocks Under $3
- Userazfar
- UserMy Portfolio
- UserNUKE PORTFOLIO
Latest ACAD Headlines from TheStreet
- 22 Biopharma Stocks With Breakout Potential in 2012 05.22.12 | 08:05 am
- ACADIA Stock Gaps Down On Today's Open (ACAD) 04.26.12 | 09:04 am
- ACADIA Pharmaceuticals Inc. Stock Downgraded (ACAD) 04.11.12 | 05:04 am
- 8 Stocks Under $10 Moving Higher 03.20.12 | 12:03 pm
- ACADIA Stock Soars (ACAD) 03.13.12 | 03:03 pm
- 5 Stocks Under $5 Making Big Moves 03.13.12 | 02:03 pm
- ACADIA Stock Soars (ACAD) 01.18.12 | 04:01 pm
- 7 Stocks Under $10 Ripping Higher 12.20.11 | 02:12 pm
- Acadia Pharmaceuticals: Investing With No Safety Net 06.24.11 | 10:06 am
- 10 Pharma Stocks Under $3 06.16.11 | 01:06 pm
Press Releases for ACAD
- ACADIA Pharmaceuticals To Webcast Educational Program On Parkinson’s Disease Psychosis On May 22, 2012 - Business Wire 05.15.12 | 09:05 am
- ACADIA Pharmaceuticals Reports First Quarter 2012 Financial Results - Business Wire 05.08.12 | 04:05 pm
- ACADIA Pharmaceuticals To Present At The 19th Annual Future Leaders In The Biotech Industry Conference On April 20, 2012 - Business Wire 04.13.12 | 09:04 am
- ACADIA Pharmaceuticals To Present At The 11th Annual Needham Healthcare Conference On April 3, 2012 - Business Wire 03.28.12 | 09:03 am
- ACADIA Pharmaceuticals Awarded New Grant From The Michael J. Fox Foundation For Development Of Nurr1-RXR Selective Agonists To Treat Parkinson’s Disease - Business Wire 03.27.12 | 09:03 am
- ACADIA Pharmaceuticals Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2011 - Business Wire 03.06.12 | 04:03 pm
- ACADIA Pharmaceuticals Announces Extension Of Drug Discovery Collaboration With Allergan, Inc. - Business Wire 03.05.12 | 09:03 am
- ACADIA Pharmaceuticals To Present At Upcoming Investor Conferences - Business Wire 02.29.12 | 09:02 am
- ACADIA Pharmaceuticals To Announce Fourth Quarter And Full Year 2011 Financial Results On March 6, 2012 - Business Wire 02.28.12 | 09:02 am
- ACADIA Pharmaceuticals To Present At The 14th Annual BIO CEO & Investor Conference On February 13, 2012 - Business Wire 02.06.12 | 09:02 am
Partner Headlines for ACAD
- Time To Take Another Look At The Biotechnology Sector - Seeking Alpha 04.09.12 | 09:04 am
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- 7 Healthcare Stocks Undervalued By Earnings Growth And Cash Flows - Seeking Alpha 02.03.12 | 07:02 pm
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 01.25.12 | 09:01 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 01.23.12 | 09:01 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 01.19.12 | 09:01 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 01.17.12 | 09:01 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 01.13.12 | 09:01 am
- 10 Biotech Stocks Undervalued By Levered Free Cash Flows - Seeking Alpha 12.07.11 | 08:12 am
